ZLAB Stock Analysis: Buy, Sell, or Hold?
ZLAB - Zai Lab Limited American Depositary Shares
$18.61
-0.49 (-2.57%)
▼
5d:
-9.62%
30d:
-14.95%
90d:
-5.63%
HOLD
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When ZLAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ZLAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ZLAB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ZLAB is currently trading at $18.61, which is considered oversold relative to its 30-day fair value range of $19.88 to $23.11.
Technical Outlook: Technically, ZLAB is in a uptrend. Immediate support is located at $18.03, while resistance sits at $21.33.
Market Sentiment: ZLAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $33.78 (+76.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ZLAB is in a uptrend. Immediate support is located at $18.03, while resistance sits at $21.33.
Market Sentiment: ZLAB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $33.78 (+76.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.88 -
$23.11
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 76.8% below Wall St target ($33.78)
- CAUTION: 5-day price weakness (-9.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$19.88 -
$23.11
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.03
Resistance Level
$21.33
Current Trend
Uptrend
Technical data as of
May 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.94
Wall Street Target
$33.78
(+76.8%)
Revenue Growth (YoY)
-6.5%
Profit Margin
-39.3%
Share & Embed Analysis
Last updated: May 22, 2026 5:00 PM ET
Data refreshes hourly during market hours. Next update: 6:00 PM
Data refreshes hourly during market hours. Next update: 6:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZLAB showing a specific setup today?
Insider Activity (6 Months)
1
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Rafael Amado
SELL
2739 shares
2026-04-06
Yajing Chen
SELL
853 shares
2026-04-06
Ying Du
SELL
2653 shares
2026-04-06
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 62 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$203 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 54 HOLD |
